DE60117777D1 - Acylierte zyklodextrin guest-inklusion komplexe - Google Patents
Acylierte zyklodextrin guest-inklusion komplexeInfo
- Publication number
- DE60117777D1 DE60117777D1 DE60117777T DE60117777T DE60117777D1 DE 60117777 D1 DE60117777 D1 DE 60117777D1 DE 60117777 T DE60117777 T DE 60117777T DE 60117777 T DE60117777 T DE 60117777T DE 60117777 D1 DE60117777 D1 DE 60117777D1
- Authority
- DE
- Germany
- Prior art keywords
- inclusion complex
- acylated
- molecule
- cyclodextrine
- guest
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0491—Sugars, nucleosides, nucleotides, oligonucleotides, nucleic acids, e.g. DNA, RNA, nucleic acid aptamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US20350000P | 2000-05-11 | 2000-05-11 | |
US203500P | 2000-05-11 | ||
US20571500P | 2000-05-19 | 2000-05-19 | |
US205715P | 2000-05-19 | ||
PCT/US2001/013499 WO2001085218A2 (en) | 2000-05-11 | 2001-04-26 | Acylated cyclodextrin guest inclusion complexes |
Publications (2)
Publication Number | Publication Date |
---|---|
DE60117777D1 true DE60117777D1 (de) | 2006-05-04 |
DE60117777T2 DE60117777T2 (de) | 2006-08-17 |
Family
ID=26898664
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60117777T Expired - Fee Related DE60117777T2 (de) | 2000-05-11 | 2001-04-26 | Acylierte zyclodextrin guest-inklusion komplexe |
Country Status (7)
Country | Link |
---|---|
US (2) | US20020025946A1 (de) |
EP (1) | EP1280559B1 (de) |
JP (1) | JP2003532757A (de) |
AT (1) | ATE319480T1 (de) |
AU (1) | AU2001255709A1 (de) |
DE (1) | DE60117777T2 (de) |
WO (1) | WO2001085218A2 (de) |
Families Citing this family (57)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060025388A1 (en) | 1999-04-30 | 2006-02-02 | Glick Gary D | Compositions and methods relating to novel compounds and targets thereof |
US7572788B2 (en) * | 1999-04-30 | 2009-08-11 | The Regents Of The University Of Michigan | Compositions and methods relating to novel compounds and targets thereof |
DK1143946T3 (da) * | 1999-04-30 | 2004-06-07 | Univ Michigan | Anvendelse af benzodiazepiner til behandling af autoimmune sygdomme induceret af apoptose |
US20040176358A1 (en) * | 1999-04-30 | 2004-09-09 | The Regents Of The University Of Michigan | Compositions and methods relating to novel compounds and targets thereof |
US20050113460A1 (en) * | 1999-04-30 | 2005-05-26 | The Regents Of The University Of Michigan | Compositions and methods relating to novel compounds and targets thereof |
JP2003321474A (ja) * | 2002-04-30 | 2003-11-11 | Kentetsuku:Kk | 包接化合物 |
EP1551334A4 (de) * | 2002-06-10 | 2006-12-13 | Leo Rubin | Medizinische vorrichtung für die abgabe von pharmazeutischen mitteln in ein lumen |
US7645474B1 (en) * | 2003-07-31 | 2010-01-12 | Advanced Cardiovascular Systems, Inc. | Method and system of purifying polymers for use with implantable medical devices |
US7785512B1 (en) | 2003-07-31 | 2010-08-31 | Advanced Cardiovascular Systems, Inc. | Method and system of controlled temperature mixing and molding of polymers with active agents for implantable medical devices |
US20070020196A1 (en) * | 2003-12-31 | 2007-01-25 | Pipkin James D | Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid prepared from a unit dose suspension |
US20070020298A1 (en) * | 2003-12-31 | 2007-01-25 | Pipkin James D | Inhalant formulation containing sulfoalkyl ether gamma-cyclodextrin and corticosteroid |
US20070020299A1 (en) | 2003-12-31 | 2007-01-25 | Pipkin James D | Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid |
AU2004312095A1 (en) | 2003-12-31 | 2005-07-21 | Cydex Pharmaceuticals, Inc. | Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid prepared from a unit dose suspension |
ATE446581T1 (de) * | 2004-03-12 | 2009-11-15 | Trinity College Dublin | Magnetoresistives medium |
US20050208093A1 (en) | 2004-03-22 | 2005-09-22 | Thierry Glauser | Phosphoryl choline coating compositions |
US20050272723A1 (en) * | 2004-04-27 | 2005-12-08 | The Regents Of The University Of Michigan | Methods and compositions for treating diseases and conditions associated with mitochondrial function |
US20060052369A1 (en) * | 2004-09-07 | 2006-03-09 | The Regents Of The University Of Michigan | Compositions and methods relating to novel compounds and targets thereof |
FR2877846B1 (fr) | 2004-11-15 | 2008-12-05 | Univ Lille Sciences Tech | Biomateriaux porteurs de cyclodextrines aux proprietes d'absorption ameliorees et de liberation progressive et retardee de molecules therapeutiques |
AU2006203946B2 (en) * | 2005-01-03 | 2009-07-23 | The Regents Of The University Of Michigan | Compositions and methods relating to novel compounds and targets thereof |
AU2006309291B2 (en) | 2005-06-01 | 2010-05-27 | The Regents Of The University Of Michigan | Unsolvated benzodiazepine compositions and methods |
DE102005033543A1 (de) * | 2005-07-14 | 2007-01-18 | Grünenthal GmbH | Ein einen Duftstoff aufweisendes transdermales therapeutisches System |
US20070105844A1 (en) * | 2005-10-26 | 2007-05-10 | Regents Of The University Of Michigan | Therapeutic compositions and methods |
CA2628193C (en) | 2005-11-01 | 2012-08-14 | The Regents Of The University Of Michigan | Novel 1,4-benzodiazepine-2,5-diones with therapeutic properties |
WO2007058247A1 (ja) * | 2005-11-17 | 2007-05-24 | Daikin Industries, Ltd. | フルオロポリエーテル分子の包接化合物 |
US20070185066A1 (en) * | 2005-12-20 | 2007-08-09 | Verus Pharmaceuticals, Inc. | Systems and methods for the delivery of corticosteroids |
US20070178050A1 (en) * | 2005-12-20 | 2007-08-02 | Verus Pharmaceuticals, Inc. | Methods and systems for the delivery of corticosteroids having an increased lung depositon |
US20070197486A1 (en) * | 2005-12-20 | 2007-08-23 | Verus Pharmaceuticals, Inc. | Methods and systems for the delivery of corticosteroids |
US20070249572A1 (en) * | 2005-12-20 | 2007-10-25 | Verus Pharmaceuticals, Inc. | Systems and methods for the delivery of corticosteroids |
WO2007095341A2 (en) * | 2006-02-15 | 2007-08-23 | Tika Läkemedel Ab | Sterilization of corticosteroids with reduced mass loss |
US7759338B2 (en) * | 2006-04-27 | 2010-07-20 | The Regents Of The University Of Michigan | Soluble 1,4 benzodiazepine compounds and stable salts thereof |
KR100718280B1 (ko) * | 2006-06-08 | 2007-05-16 | 재단법인서울대학교산학협력재단 | 사이클로덱스트린 유도체 입자를 도입한 가소제 유출저감형 폴리염화비닐 성형체 및 그 제조방법 |
WO2007146167A1 (en) | 2006-06-09 | 2007-12-21 | The Regents Of The University Of Michigan | Compositions and methods relating to novel compounds and targets thereof |
US11090250B2 (en) | 2007-03-01 | 2021-08-17 | The Procter & Gamble Company | Compositions and/or articles comprising cyclodextrin complexing material |
US10149910B2 (en) * | 2007-03-01 | 2018-12-11 | The Procter & Gamble Plaza | Compositions and/or articles comprising cyclodextrin complexing material |
AU2008226532B2 (en) | 2007-03-09 | 2011-09-22 | The Regents Of The University Of Michigan | Compositions and methods relating to novel compounds and targets thereof |
JP5182661B2 (ja) * | 2007-07-31 | 2013-04-17 | 株式会社ネオス | 固形油及び固形油の製造方法 |
KR100929920B1 (ko) * | 2007-09-05 | 2009-12-04 | 주식회사 마크로케어 | 사이클로덱스트린 및 이의 유도체에 소수성 생리활성성분이 포접된 포접체의 제조방법 및 이로써 제조된포접체의 용도 |
AR068374A1 (es) * | 2007-09-06 | 2009-11-11 | Combino Pharm Sl | Nuevas composiciones farmaceuticas del complejo lamivudina beta - ciclodextrina |
US8324258B2 (en) | 2007-09-14 | 2012-12-04 | The Regents Of The University Of Michigan | F1F0-ATPase inhibitors and related methods |
BRPI0820477A2 (pt) | 2007-11-06 | 2015-06-16 | Univ Michigan | Compostos de benzodiazepinona úteis no tratamento de afecções da pele |
US7999741B2 (en) * | 2007-12-04 | 2011-08-16 | Avaya Inc. | Systems and methods for facilitating a first response mission at an incident scene using precision location |
EP2352724B1 (de) | 2008-09-11 | 2015-04-22 | The Regents of the University of Michigan | Arylguanidine-f1f0-aptase inhibitoren und deren therapeutischen verwendung |
US8604023B2 (en) | 2009-04-17 | 2013-12-10 | The Regents Of The University Of Michigan | 1,4-benzodiazepinone compounds and their use in treating cancer |
US8673897B2 (en) | 2009-09-18 | 2014-03-18 | The Regents Of The University Of Michigan | Benzodiazepinone compounds and methods of treatment using same |
CN102753544A (zh) | 2009-11-17 | 2012-10-24 | 密执安大学评议会 | 具有治疗性能的1,4-苯并二氮杂*-2,5-二酮和相关化合物 |
WO2011062765A2 (en) | 2009-11-17 | 2011-05-26 | The Regents Of The University Of Michigan | 1,4-benzodiazepine-2,5-diones and related compounds with therapeutic properties |
WO2012061413A2 (en) | 2010-11-01 | 2012-05-10 | Marshall Edwards, Inc. | Isoflavonoid compositions and methods for the treatment of cancer |
US10328152B2 (en) | 2011-06-16 | 2019-06-25 | Nayan Patel | Method for stabilization and delivery of therapeutic molecules |
JP5906518B2 (ja) * | 2011-08-11 | 2016-04-20 | 地方独立行政法人鳥取県産業技術センター | シクロデキストリン包接化合物含有組成物の製造方法 |
CN116139125A (zh) | 2015-02-02 | 2023-05-23 | 梅制药公司 | 联合治疗 |
CA3035350C (en) | 2016-09-06 | 2023-05-23 | The Procter & Gamble Company | Antiperspirant and deodorant compositions comprising a hydrophilic perfume compound complexed in a cyclodextrin |
MX2019002544A (es) | 2016-09-06 | 2019-07-01 | Procter & Gamble | Composiciones en aerosol. |
WO2019177558A1 (en) * | 2018-03-16 | 2019-09-19 | T.C. Istanbul Medipol Universitesi | Inclusion complexes suitable for use as a histotripsy agent |
JP7323887B2 (ja) * | 2019-02-28 | 2023-08-09 | 国立大学法人北海道大学 | セルロースアセテートフィルム |
JP2022554420A (ja) * | 2019-10-21 | 2022-12-28 | エソレイト・リミテッド | 超微粒化合物を含む組成物およびその製造 |
CN114917365B (zh) * | 2022-06-09 | 2023-12-08 | 上海彤颜实业有限公司 | Wgx50环糊精包合物、制备方法、溶解度及环糊精包裹率测定方法 |
CN114886877B (zh) * | 2022-06-16 | 2024-02-02 | 北京海泰天正医药科技有限公司 | 奥氮平氟西汀复方口溶膜及其制备方法 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU183430B (en) * | 1981-05-12 | 1984-05-28 | Chinoin Gyogyszer Es Vegyeszet | Process for producing cyclodextrine inclusion complexes of n-bracket-1-phenylethyl-bracket closed-3,3-diphenylpropylamine or n-bracket-1-phenylethyl-bracket closed-3,3-diphenylpropylamine-hydrochloride |
JPS5921613A (ja) * | 1982-07-28 | 1984-02-03 | Takeda Chem Ind Ltd | 直腸投与製剤 |
US6146358A (en) * | 1989-03-14 | 2000-11-14 | Cordis Corporation | Method and apparatus for delivery of therapeutic agent |
HU212730B (en) * | 1990-03-28 | 1996-10-28 | Chinoin Gyogyszer Es Vegyeszet | Process for producing inclusion complexes of cyclodextrine or its derivative and 3-morpholino-sydnonimine or its salt or its tautomer and pharmaceutical compositions containing them |
FR2692168B1 (fr) * | 1992-06-16 | 1995-03-24 | Centre Nat Rech Scient | Préparation et utilisation de nouveaux systèmes colloïdaux dispersibles à base de cyclodextrine, sous forme de nanosphères. |
US5464650A (en) * | 1993-04-26 | 1995-11-07 | Medtronic, Inc. | Intravascular stent and method |
DE4414128A1 (de) * | 1994-04-22 | 1995-10-26 | Consortium Elektrochem Ind | Teilweise acylierte beta-Cyclodextrine |
JPH10194996A (ja) * | 1996-12-25 | 1998-07-28 | Janssen Pharmaceut Nv | アシル化シクロデキストリン含有製薬組成物 |
-
2001
- 2001-04-26 AU AU2001255709A patent/AU2001255709A1/en not_active Abandoned
- 2001-04-26 EP EP01928906A patent/EP1280559B1/de not_active Expired - Lifetime
- 2001-04-26 WO PCT/US2001/013499 patent/WO2001085218A2/en active IP Right Grant
- 2001-04-26 DE DE60117777T patent/DE60117777T2/de not_active Expired - Fee Related
- 2001-04-26 US US09/843,037 patent/US20020025946A1/en not_active Abandoned
- 2001-04-26 JP JP2001581871A patent/JP2003532757A/ja active Pending
- 2001-04-26 AT AT01928906T patent/ATE319480T1/de not_active IP Right Cessation
-
2003
- 2003-09-30 US US10/675,900 patent/US20040063663A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20020025946A1 (en) | 2002-02-28 |
EP1280559B1 (de) | 2006-03-08 |
WO2001085218A3 (en) | 2002-09-12 |
JP2003532757A (ja) | 2003-11-05 |
DE60117777T2 (de) | 2006-08-17 |
EP1280559A2 (de) | 2003-02-05 |
US20040063663A1 (en) | 2004-04-01 |
AU2001255709A1 (en) | 2001-11-20 |
ATE319480T1 (de) | 2006-03-15 |
WO2001085218A2 (en) | 2001-11-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60117777D1 (de) | Acylierte zyklodextrin guest-inklusion komplexe | |
DE69737834D1 (de) | Folienzusammensetzungen aus Polymerisat zur Herstellung von Kapseln | |
KR870002842A (ko) | 싸이클로덱스트린으로 제조되는 7-이소프로폭시-이소플라본의 함유착물과 그를 활성성분으로 함유하는 약리학적 조성물 및 제제 | |
BR0211028A (pt) | Solução aquosa, método para formação de associações de fármaco e polìmero, composições farmacêuticas, método para formação de uma composição farmacêutica e produto | |
CA2289202A1 (en) | Solid pharmaceutical formulations containing a physical mixture of sulfoalkyl ether cyclodextrin and a therapeutic agent | |
DE602004023725D1 (de) | Muteine von tränen-lipocalin | |
WO2003007985A3 (en) | Capsular polysaccharide solubilisation and combination vaccines | |
DK0513072T3 (da) | Forbedret cyclodextrinbaseret erythropoietinformulering | |
CA2303498A1 (en) | Dioxocyclopentyl hydroxamic acids | |
DK1392282T3 (da) | Dermatologiske og kosmetiske sammensætninger, der omfatter et furfurylderivat | |
BR0211926A (pt) | agentes para realçar a resposta imune | |
KR960700074A (ko) | 고용해성다성분봉입체착화합물(Highy soluble multicomponent inclusion complexes containing a base type drug, an acid and a cyclodextrin) | |
TR200401029T4 (tr) | Asilfenil-üre türevleri, imalat yöntemleri ve ilaç maddesi olarak kullanımları | |
GEP20063917B (en) | Pulmonary administration of chemically modified insulin | |
MEP43408A (en) | Novel fluorene carboxylic acid esters, methods for the production thereof, and use of the same as pharmaceuticals | |
MEP9309A (en) | Novel oligosaccharides, preparation method and pharmaceutical compositions containing the same | |
WO2003024899A3 (en) | CYCLIC HYDROXAMIC ACIDS AS INHIBITORS OF MATRIX METALLOPROTEINASES AND/OR TNF-α CONVERTING ENZYME (TACE) | |
GB0310919D0 (en) | Pharmaceutical compositions | |
MXPA04003199A (es) | Composicion que contiene particulas para estilizar el cabello. | |
MXPA05013390A (es) | Composicion para el cuidado de la piel que comprende un agente aclarador de la piel. | |
EP1469886B8 (de) | Lyophilisierte pharmazeutische zusammensetzung von propofol | |
WO1999040073A3 (de) | Tryptase-inhibitoren | |
HUP0104562A2 (hu) | Savegységgel rendelkező kopolimert tartalmazó hajrögzítő kozmetikai készítmény | |
NO20010940L (no) | TAN-1057 derivater | |
TR200402070T4 (tr) | Siklobüten-dion türevleri ve bunların damar sertliği tedavisinde kullanımı |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |